drugset / Trial / NCT05218486

Effect of Oral Isotretinoin on The Level of SerumYKL40 in Acne Vulgaris Patients

NCT05218486

Phase 4 Unknown 60 enrolled Alshimaa Abbas Mohamed Ebrahim
RandomizedParallel-groupDouble-blindDiagnostic

Summary

The aim of the study is to evaluate the effect of oral isotretinoin on SerumYKL40 in acne vulgaris patients.

Timeline

Start
2021-08-01
Primary completion
2022-09-30
Completion
2022-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Isotretinoin Other / unclassified 20 mg Oral
Comparator Isotretinoin Other / unclassified 40 mg Oral

Indications